Tower Research Capital (TRC)’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,224
| Closed | -$9.92K | – | 6290 |
|
|
2023
Q3 | $9.92K | Sell |
10,224
-254
| -2% | -$180 | ﹤0.01% | 4165 |
|
|
2023
Q2 | $7.34K | Sell |
10,478
-9
| -0.1% | -$5 | ﹤0.01% | 4588 |
|
|
2023
Q1 | $7K | Buy |
10,487
+4,202
| +67% | +$7.01K | ﹤0.01% | 4798 |
|
|
2022
Q4 | $9K | Buy |
6,285
+2,925
| +87% | +$5.17K | ﹤0.01% | 4323 |
|
|
2022
Q3 | $6K | Buy |
3,360
+2,212
| +193% | +$6.4K | ﹤0.01% | 5091 |
|
|
2022
Q2 | $7K | Buy |
+1,148
| New | +$10.4K | ﹤0.01% | 4852 |
|
|
2022
Q1 | – | Sell |
-824
| Closed | -$8K | – | 6788 |
|
|
2021
Q4 | $8K | Buy |
824
+619
| +302% | +$11.1K | ﹤0.01% | 4844 |
|
|
2021
Q3 | $7K | Buy |
205
+157
| +327% | +$5.09K | ﹤0.01% | 4701 |
|
|
2021
Q2 | $2K | Buy |
+48
| New | +$1.97K | ﹤0.01% | 5100 |
|
|
2021
Q1 | – | Sell |
-175
| Closed | -$6K | – | 5845 |
|
|
2020
Q4 | $6K | Buy |
+175
| New | +$5.5K | ﹤0.01% | 4578 |
|
|
2019
Q4 | – | Sell |
-25
| Closed | -$5K | – | 4586 |
|
|
2019
Q3 | $5K | Buy |
+25
| New | +$5.74K | ﹤0.01% | 3358 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | – | – | 4469 |
|
|
2019
Q1 | $0 | Buy |
+1
| New | +$335 | ﹤0.01% | 4427 |
|
|
2018
Q4 | – | Sell |
-2
| Closed | -$1K | – | 4504 |
|
|
2018
Q3 | $1K | Buy |
+2
| New | +$843 | ﹤0.01% | 3645 |
|
|
2018
Q2 | – | Sell |
-23
| Closed | -$10.8K | – | 4177 |
|
|
2018
Q1 | $11K | Buy |
+23
| New | +$11.4K | ﹤0.01% | 2444 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$1K | – | 4156 |
|
|
2017
Q3 | $1K | Sell |
1
-3
| -75% | -$2.37K | ﹤0.01% | 3690 |
|
|
2017
Q2 | $3K | Buy |
4
+3
| +300% | +$2.19K | ﹤0.01% | 2258 |
|
|
2017
Q1 | $1K | Buy |
+1
| New | +$705 | ﹤0.01% | 2879 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$1K | – | 4537 |
|
|
2016
Q3 | $1K | Buy |
+1
| New | +$1.26K | ﹤0.01% | 3408 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$1K | – | 5126 |
|
|
2016
Q1 | $1K | Sell |
1
-1
| -50% | -$1.15K | ﹤0.01% | 3839 |
|
|
2015
Q4 | $2K | Buy |
+2
| New | +$2.61K | ﹤0.01% | 3845 |
|
|
2014
Q3 | – | Sell |
-1
| Closed | -$3K | – | 4999 |
|
|
2014
Q2 | $3K | Sell |
1
-5
| -83% | -$18.8K | ﹤0.01% | 3261 |
|
|
2014
Q1 | $23K | Buy |
6
+5
| +500% | +$22.3K | ﹤0.01% | 1760 |
|
|
2013
Q4 | $5K | Buy |
+1
| New | +$3.79K | ﹤0.01% | 3557 |
|
Other funds holding FRTX
Tower Research Capital (TRC)'s FRTX Position: Q4 2023 in Review
Tower Research Capital (TRC) sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 10,224 shares — an estimated $9.92K sold.
Tower Research Capital (TRC) first reported a position in FRTX in Q4 2013 and held it in 23 quarters. The position peaked at $23K in Q1 2014. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.
- Tower Research Capital (TRC) reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 10,224 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $9.92K.
- Tower Research Capital (TRC) first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 23 quarters.
- Tower Research Capital (TRC)'s Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $23K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.